CCCXU
Churchill Capital Corp X focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in New York, New York.
CCCXU (CCCXU) - Net Assets
Latest net assets as of September 2025: $381.57 Million USD
Based on the latest financial reports, CCCXU (CCCXU) has net assets worth $381.57 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($421.27 Million) and total liabilities ($39.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $381.57 Million |
| % of Total Assets | 90.58% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CCCXU - Net Assets Trend (2024–2024)
This chart illustrates how CCCXU's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CCCXU (2024–2024)
The table below shows the annual net assets of CCCXU from 2024 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-26.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CCCXU's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $863.00 | % |
| Other Components | $24.14K | % |
| Total Equity | $-26.91K | 100.00% |
CCCXU Competitors by Market Cap
The table below lists competitors of CCCXU ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guggenheim Taxable Municipal Managed Duration Trust
NYSE:GBAB
|
$140.86K |
|
CKD Bio Corp.
KQ:063160
|
$140.88K |
|
ENAGAS (EG4.SG)
STU:EG4
|
$140.88K |
|
Nu Asset FICFII Em Debentures De Infraestrutura Renda Fixa Credito Privado
SA:NUIF11
|
$140.99K |
|
SOLARHYBRID
BE:SHC
|
$140.71K |
|
Canada Packers Inc.
TO:CPKR
|
$140.66K |
|
HSBC HLDG
MU:HBC1
|
$140.57K |
|
TOBA Investments Bonds
CO:TOIBO
|
$140.47K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CCCXU's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CCCXU's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2024-12-31 | $0.00 | $15.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CCCXU utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-49.22K |
Industry Comparison
This section compares CCCXU's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CCCXU (CCCXU) | $381.57 Million | 0.00% | 0.10x | $140.85K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |